Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 14 of 14
Full-Text Articles in Law
Table Of Contents, Annals Of Health Law
Table Of Contents, Annals Of Health Law
Annals of Health Law and Life Sciences
No abstract provided.
Table Of Contents, Annals Of Health Law
Table Of Contents, Annals Of Health Law
Annals of Health Law and Life Sciences
No abstract provided.
Diseases Endemic In Developing Countries: How To Incentive Innovation, Ann Weilbaecher
Diseases Endemic In Developing Countries: How To Incentive Innovation, Ann Weilbaecher
Annals of Health Law and Life Sciences
This comment addresses the inadequacies of research and development for diseases endemic in developing countries and explores how the patent system can inhibit innovation for new drugs for neglected diseases. The author analyzes four strategies to encourage innovation, including open source initiatives, patent pools, prizes, and wild card patent extensions, and examines how these alternative systems may spur innovation while balancing cost concerns held by drug manufacturers and purchasers. The author concludes that a combination of solutions may provide the best framework for the creation of essential medicines for neglected diseases.
Medical Malpractice Reform: A Silver Bullet For The Health Care Crisis?, Ian Barney
Medical Malpractice Reform: A Silver Bullet For The Health Care Crisis?, Ian Barney
Public Interest Law Reporter
No abstract provided.
Morality Versus Vital Healthcare: The Debate Over Bush's Health And Human Services' Midnight Regulation, Lesley Shermeta
Morality Versus Vital Healthcare: The Debate Over Bush's Health And Human Services' Midnight Regulation, Lesley Shermeta
Public Interest Law Reporter
No abstract provided.
Second Class Citizens: Illinois' Rural Uninsured And The Hospital Uninsured Patient Discount Act, Bill Metzinger
Second Class Citizens: Illinois' Rural Uninsured And The Hospital Uninsured Patient Discount Act, Bill Metzinger
Public Interest Law Reporter
No abstract provided.
Healthcare Standards In Immigration Detention Centers, Ana Maria Echiburu
Healthcare Standards In Immigration Detention Centers, Ana Maria Echiburu
Public Interest Law Reporter
No abstract provided.
A Change For The Better: The Ada Amendments Act Of 2008, Jason Lewis
A Change For The Better: The Ada Amendments Act Of 2008, Jason Lewis
Public Interest Law Reporter
No abstract provided.
Legal, Ethical, And Conceptual Bottlenecks To The Development Of Useful Genomic Tests, Michael Tomasson
Legal, Ethical, And Conceptual Bottlenecks To The Development Of Useful Genomic Tests, Michael Tomasson
Annals of Health Law and Life Sciences
This article discusses advances in genomic research in the context of the debate surrounding gene patent rights and the limited rights of patient-participants in translational research. In addition, the author explores statutory and regulatory hurdles to advances in disease diagnosis, such the Bayh-Dole Act, Medicare Legislation, and the Health Insurance Portability and Accountability Act. The author questions the effectiveness of increasingly commercialized academic research and the limited success of the private sector in genomic research. The author concludes that future genomic research will require significantly increased patient participation, which may necessitate a reshaping of the pharmaceutical approach to medicine and …
Health Reform’S Newest Moment In Time, John D. Blum
Health Reform’S Newest Moment In Time, John D. Blum
Faculty Publications & Other Works
No abstract provided.
An Introduction - Patents Versus Patients: Must We Choose, Cynthia M. Ho, Ann Weilbaecher
An Introduction - Patents Versus Patients: Must We Choose, Cynthia M. Ho, Ann Weilbaecher
Annals of Health Law and Life Sciences
No abstract provided.
Prizes For Innovation Of New Medicines And Vaccines, James Love, Tim Hubbard
Prizes For Innovation Of New Medicines And Vaccines, James Love, Tim Hubbard
Annals of Health Law and Life Sciences
This article argues that prizes can help stimulate medical innovation, control costs and ensure greater access to new medicines and vaccines. The authors explore four increasingly ambitious prize options to reward medical innovation, each addressing flaws in the current patent system. The first option promotes innovation through a large prize fund linked to the impact on health outcomes; the second option rewards the sharing of knowledge, data, and technology with open source dividends; the third option awards prizes for interim benchmarks and discrete technical problems; and the final option removes the exclusive right to use patented inventions in upstream research …
Patents & (And) The Progress Of Personalized Medicine: Biomarkers Research As Lens, Matthew Herder
Patents & (And) The Progress Of Personalized Medicine: Biomarkers Research As Lens, Matthew Herder
Annals of Health Law and Life Sciences
This article addresses the barriers to personalized medicine, focusing on the burgeoning field of biomarkers research. The author begins by framing intellectual property issues as more than a product of industry incentives and suggests that these issues are deeply entangled with other barriers facing personalized medicine such as regulatory framework deficiencies. The author proposes a set of future research questions to more fully define the barriers to biomarkers research and to uncover which corrective measures may be effective. The author concludes by recommending an integration of regulatory and patent reforms, with a call to action by scholars, scientists, representatives of …
Patents With An "I" = Patients, Alice O. Martin, Sendil K. Devadas
Patents With An "I" = Patients, Alice O. Martin, Sendil K. Devadas
Annals of Health Law and Life Sciences
The authors address how patent protection in the United States is often quite narrow in scope, difficult to obtain, and insufficient in duration, thus stifling research and development of potential breakthrough pharmaceuticals. The authors further posit that countries that have enacted stronger intellectual property rights and research incentives have seen tremendous increases in foreign direct investment. In addressing critics of the current patent system, the authors show that alternatives to biotechnology patents would not demonstrably improve innovation and development of beneficial medicines. The authors conclude that given the substantial evidence of the patent system's benefits, and the mere speculation that …